Price Alert

BioCardia Inc. (BCDAW)

NASDAQ: BCDAW · Real-Time Price · USD

0.01

0.00 (58.73%)

At close: Aug 02, 2024, 10:00 PM

BioCardia Statistics

Share Statistics

BioCardia has 1.66M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	1.66M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	0.38%
Shares Floating	n/a
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

The PE ratio is -0.75 and the forward PE ratio is null. BioCardia's PEG ratio is 0.01.

PE Ratio	-0.75
Forward PE	n/a
PS Ratio	103.13
Forward PS	n/a
PB Ratio	7.15
P/FCF Ratio	-0.74
PEG Ratio	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioCardia.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.14.

Current Ratio	1.13
Quick Ratio	1.13
Debt / Equity	1.14
Debt / EBITDA	-0.12
Debt / FCF	-0.12
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$3.63K
Profits Per Employee	$-496.63K
Employee Count	16
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.36, so BioCardia's price volatility has been higher than the market average.

Beta	1.36
52-Week Price Change	n/a
50-Day Moving Average	0.02
200-Day Moving Average	0.39
Relative Strength Index (RSI)	39.09
Average Volume (20 Days)	n/a

Income Statement

In the last 12 months, BioCardia had revenue of 58K and earned -7.95M in profits. Earnings per share was -2.9.

Revenue	58K
Gross Profit	58K
Operating Income	-8M
Net Income	-7.95M
EBITDA	-7.93M
EBIT	-8M
Earnings Per Share (EPS)	-2.9

Full Income Statement

Balance Sheet

The company has 2.37M in cash and 951K in debt, giving a net cash position of 1.42M.

Cash & Cash Equivalents	2.37M
Total Debt	951K
Net Cash	1.42M
Retained Earnings	-160.12M
Total Assets	3.72M
Working Capital	301K

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.03M and capital expenditures -6K, giving a free cash flow of -8.03M.

Operating Cash Flow	-8.03M
Capital Expenditures	-6K
Free Cash Flow	-8.03M
FCF Per Share	-2.93

Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -13794.83% and -13700%.

Gross Margin	100%
Operating Margin	-13794.83%
Pretax Margin	-13700%
Profit Margin	-13700%
EBITDA Margin	-13679.31%
EBIT Margin	-13794.83%
FCF Margin	-13848.28%

Dividends & Yields

BCDAW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for BCDAW.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-67.17
Piotroski F-Score	2